As the global economy mends, the 2021 growth of Bacillus Calmette Guerin Vaccine will have significant change from previous year. According to our (Publisher) latest study, the global Bacillus Calmette Guerin Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bacillus Calmette Guerin Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Bacillus Calmette Guerin Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Bacillus Calmette Guerin Vaccine market, reaching US$ million by the year 2028. As for the Europe Bacillus Calmette Guerin Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Bacillus Calmette Guerin Vaccine players cover Merck, Sanofi Pasteur, Japan BCG Lab, and China National Biotec, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacillus Calmette Guerin Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Immune Type
Therapy Type
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Funda??o Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacillus Calmette Guerin Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bacillus Calmette Guerin Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bacillus Calmette Guerin Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Bacillus Calmette Guerin Vaccine Segment by Type
2.2.1 Immune Type
2.2.2 Therapy Type
2.3 Bacillus Calmette Guerin Vaccine Sales by Type
2.3.1 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Bacillus Calmette Guerin Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bacillus Calmette Guerin Vaccine Sale Price by Type (2017-2022)
2.4 Bacillus Calmette Guerin Vaccine Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Bacillus Calmette Guerin Vaccine Sales by Application
2.5.1 Global Bacillus Calmette Guerin Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Bacillus Calmette Guerin Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bacillus Calmette Guerin Vaccine Sale Price by Application (2017-2022)
3 Global Bacillus Calmette Guerin Vaccine by Company
3.1 Global Bacillus Calmette Guerin Vaccine Breakdown Data by Company
3.1.1 Global Bacillus Calmette Guerin Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Bacillus Calmette Guerin Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Bacillus Calmette Guerin Vaccine Revenue by Company (2020-2022)
3.2.2 Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Bacillus Calmette Guerin Vaccine Sale Price by Company
3.4 Key Manufacturers Bacillus Calmette Guerin Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bacillus Calmette Guerin Vaccine Product Location Distribution
3.4.2 Players Bacillus Calmette Guerin Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bacillus Calmette Guerin Vaccine by Geographic Region
4.1 World Historic Bacillus Calmette Guerin Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Bacillus Calmette Guerin Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bacillus Calmette Guerin Vaccine Annual Revenue by Geographic Region
4.2 World Historic Bacillus Calmette Guerin Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Bacillus Calmette Guerin Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bacillus Calmette Guerin Vaccine Annual Revenue by Country/Region
4.3 Americas Bacillus Calmette Guerin Vaccine Sales Growth
4.4 APAC Bacillus Calmette Guerin Vaccine Sales Growth
4.5 Europe Bacillus Calmette Guerin Vaccine Sales Growth
4.6 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Growth
5 Americas
5.1 Americas Bacillus Calmette Guerin Vaccine Sales by Country
5.1.1 Americas Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022)
5.1.2 Americas Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022)
5.2 Americas Bacillus Calmette Guerin Vaccine Sales by Type
5.3 Americas Bacillus Calmette Guerin Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacillus Calmette Guerin Vaccine Sales by Region
6.1.1 APAC Bacillus Calmette Guerin Vaccine Sales by Region (2017-2022)
6.1.2 APAC Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2022)
6.2 APAC Bacillus Calmette Guerin Vaccine Sales by Type
6.3 APAC Bacillus Calmette Guerin Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bacillus Calmette Guerin Vaccine by Country
7.1.1 Europe Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022)
7.1.2 Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022)
7.2 Europe Bacillus Calmette Guerin Vaccine Sales by Type
7.3 Europe Bacillus Calmette Guerin Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bacillus Calmette Guerin Vaccine by Country
8.1.1 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Type
8.3 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bacillus Calmette Guerin Vaccine
10.3 Manufacturing Process Analysis of Bacillus Calmette Guerin Vaccine
10.4 Industry Chain Structure of Bacillus Calmette Guerin Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bacillus Calmette Guerin Vaccine Distributors
11.3 Bacillus Calmette Guerin Vaccine Customer
12 World Forecast Review for Bacillus Calmette Guerin Vaccine by Geographic Region
12.1 Global Bacillus Calmette Guerin Vaccine Market Size Forecast by Region
12.1.1 Global Bacillus Calmette Guerin Vaccine Forecast by Region (2023-2028)
12.1.2 Global Bacillus Calmette Guerin Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bacillus Calmette Guerin Vaccine Forecast by Type
12.7 Global Bacillus Calmette Guerin Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Bacillus Calmette Guerin Vaccine Product Offered
13.1.3 Merck Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product Offered
13.2.3 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
13.3.1 Japan BCG Lab Company Information
13.3.2 Japan BCG Lab Bacillus Calmette Guerin Vaccine Product Offered
13.3.3 Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Japan BCG Lab Main Business Overview
13.3.5 Japan BCG Lab Latest Developments
13.4 China National Biotec
13.4.1 China National Biotec Company Information
13.4.2 China National Biotec Bacillus Calmette Guerin Vaccine Product Offered
13.4.3 China National Biotec Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 China National Biotec Main Business Overview
13.4.5 China National Biotec Latest Developments
13.5 AJ Vaccines
13.5.1 AJ Vaccines Company Information
13.5.2 AJ Vaccines Bacillus Calmette Guerin Vaccine Product Offered
13.5.3 AJ Vaccines Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AJ Vaccines Main Business Overview
13.5.5 AJ Vaccines Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India Bacillus Calmette Guerin Vaccine Product Offered
13.6.3 Serum Institute of India Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
13.7 Intervax
13.7.1 Intervax Company Information
13.7.2 Intervax Bacillus Calmette Guerin Vaccine Product Offered
13.7.3 Intervax Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Intervax Main Business Overview
13.7.5 Intervax Latest Developments
13.8 GSBPL
13.8.1 GSBPL Company Information
13.8.2 GSBPL Bacillus Calmette Guerin Vaccine Product Offered
13.8.3 GSBPL Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GSBPL Main Business Overview
13.8.5 GSBPL Latest Developments
13.9 Statens Serum Institute
13.9.1 Statens Serum Institute Company Information
13.9.2 Statens Serum Institute Bacillus Calmette Guerin Vaccine Product Offered
13.9.3 Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Statens Serum Institute Main Business Overview
13.9.5 Statens Serum Institute Latest Developments
13.10 Biomed Lublin
13.10.1 Biomed Lublin Company Information
13.10.2 Biomed Lublin Bacillus Calmette Guerin Vaccine Product Offered
13.10.3 Biomed Lublin Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Biomed Lublin Main Business Overview
13.10.5 Biomed Lublin Latest Developments
13.11 ANLIS Malbran
13.11.1 ANLIS Malbran Company Information
13.11.2 ANLIS Malbran Bacillus Calmette Guerin Vaccine Product Offered
13.11.3 ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 ANLIS Malbran Main Business Overview
13.11.5 ANLIS Malbran Latest Developments
13.12 Funda